Qiagen, Hilden, Germany, has partnered with Genohm, Ghent, Belgium, to support users of the GeneReader next-generation sequencing (NGS) system by integrating the NGS workflow with Genohm’s laboratory information management systems (LIMS). Qiagen’s NGS system is supported by GeneRead Link, a middleware system codeveloped by the two companies to ensure complete chain of custody from sample processing to final reports, with full connectivity into LIMS systems.
In addition, GeneReader NGS system customers who do not already have a LIMS solution can benefit from easy connectivity into Genohm’s proprietary SLims solution to help manage all data across the laboratory. Both companies will continue to enhance GeneRead Link and adapt the middleware solution as required to support future GeneReader workflows.
“The value of next-generation sequencing comes from the insights a lab generates, and our GeneReader NGS system is uniquely designed to enable any laboratory to deliver actionable results from NGS,” says Jonathan Arnold, senior director of marketing for next-generation sequencing at Qiagen. “We are pleased to partner with Genohm to deliver GeneRead Link, greatly simplifying management of the sequencing information and providing connectivity with most LIMS platforms. Offering GeneReader NGS customers access to Genohm’s proprietary SLims solution, an easy-to-use LIMS and electronic laboratory notebook system, broadens the solution to manage the whole laboratory’s data.”
“Our focus is on making life in the lab easier, and working with Qiagen enables us to offer Genohm’s user-friendly solutions to more customers around the globe, particularly clinical research and diagnostic labs deploying NGS,” says Frederik Decouttere, CEO of Genohm. “SLims is a flexible, feature-complete, compliant, and easy-to-use solution consisting of a LIMS and an electronic laboratory notebook (ELN) that automates interfaces, integrating information flow from every machine in a laboratory, from initial sample shipment to final reporting of results. By reducing administrative time, SLims frees staff members to devote themselves to unlocking insights that improve outcomes.”
The GeneReader NGS system, launched in late 2015, was developed to provide a simple, cost-effective way for clinical testing laboratories to take advantage of NGS technology and improve outcomes. In June 2016, Qiagen expanded the GeneReader for use with noninvasive liquid biopsies, adding to its use with formalin-fixed, paraffin-embedded tissue samples. Qiagen has also announced the relaunch of the system in the US market based on several upgrades made to its new sequencing chemistry.
GeneRead Link middleware, the only standardized interface to manage NGS data from sample preparation to reporting of results, interfaces with any LIMS to maximize efficiency and provide compliant management.